Linezolid and Serotonin Toxicity [2]

Clinical Infectious Diseases

Volumn 37, Issue 9, 2003, Pages 1274-1275

  Gillman, P Ken ^a,b  

^a JAMES COOK UNIVERSITY   (Australia)

^b Pioneer Valley Private Hospital   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CHLORPROMAZINE; CYPROHEPTADINE; DULOXETINE; LINEZOLID; MONOAMINE OXIDASE INHIBITOR; NARCOTIC ANALGESIC AGENT; NORADRENALIN UPTAKE INHIBITOR; PETHIDINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; VENLAFAXINE;

AGITATION; DRUG INDUCED DISEASE; FEVER; HUMAN; HYPERREFLEXIA; LETTER; MUSCLE HYPERTONIA; MYOCLONUS; PRIORITY JOURNAL; PYRAMIDAL SIGN; SEROTONIN SYNDROME; SYMPTOMATOLOGY;

ACETAMIDES; HUMANS; OXAZOLIDINONES; PROTEIN SYNTHESIS INHIBITORS; SEROTONIN; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 0242490744     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/378895     Document Type: Letter

References (4)

1. Bernard L, Stern R, Lew D, Hoffmeyer P. Serotonin syndrome after concomitant treatment with linezolid and citalopram. Clin Infect Dis 2003; 36:1197.
2. Dunkley E, Isbister G, Sibbritt D, Dawson A, Whyte I. The Hunter Serotonin Toxicity Criteria: a simple and accurate diagnostic decision rule for serotonin toxicity. Q J Med 2003; 96: 635-42.
3. Gillman PK. Serotonin syndrome: history and risk. Fundam Clin Pharmacol 1998; 12:482-91.
4. Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol 1999; 13:100-9.